MAYORS UNDETERRED BY PARIS CLIMATE ACCORD WITHDRAWAL
Bipartisan Group Reinforces Commitment to Reduce Greenhouse Gas Emissions in Cities on Conference Call Today
Washington, D.C, June 02, 2017 (GLOBE NEWSWIRE) --
The nation's mayors today said they are undeterred by the decision to withdraw from the Paris Climate Accord and expressed their unwavering commitment to continue efforts to reduce greenhouse gas emissions to alleviate the impacts of global warming despite what happens at the national level.
On a conference call today hosted by The U.S. Conference of Mayors, New Orleans (LA) Mayor Mitch Landrieu, who serves as USCM Vice President, stressed strong opposition to the withdrawal and explained that the bipartisan organization has taken an active role for many years to combat climate change. "From Kyoto to Paris to today, on behalf of the Conference, it is our collective opinion that withdrawal from the Paris Climate Accord is a shortsighted decision. While we don't necessarily disagree on 'America First,' it cannot be 'America Only' - pitting environmental protection against economic growth, which is a false choice. Mayors will do what we need to do on our own. This is not the first time when we have had to act without Washington."
"We see the withdrawal from the Paris Climate Accord as an abdication of American leadership and America's mayors will certainly fill that void," said Phoenix (AZ) Mayor Greg Stanton, USCM Environment Committee Chair. "We will symbolically sign on and take actions necessary so that America meets its obligations under the Paris Accord, despite actions of this Administration. This is a local issue that mayors must come together on and we will not shirk our responsibilities. The eyes of the world are upon us and they are disappointed. We want to make sure that they are heartened by the actions of American mayors in a bipartisan way. America's mayors are stepping up to the plate and taking on a greater international role as a result."
Burnsville (MN) Mayor Elizabeth Kautz, USCM Past President said, "Mayors won't quit. We care about the environment and energy efficiency. Mayors will make a difference. Mayors will come together to get this done. We must protect the planet."
Kautz also underscored that the nation's mayors will focus on this issue during The Conference of Mayors Annual Meeting this June 23-27 in Miami Beach, when they will gather to reaffirm their long-term commitment to addressing climate disruption and celebrate mayors who have made significant strides locally.
Carmel (IN) Mayor Jim Brainard, who serves as the Conference's Energy Independence and Climate Protection Task Force Co-Chair, stressed the bipartisan efforts of mayors on this issue. "Eighty percent of Carmel votes Republican, but I have yet to meet a citizen who wants to drink dirty water, breathe dirty air and doesn't want to leave the earth in better condition for their children and grandchildren. President Trump is measuring greatness by the wrong yard stick. We need to measure our greatness by our ability to provide clean water and clean air to our citizens."
New Bedford (MA) Mayor Jon Mitchell, Conference Energy Committee Chair, said "New Bedford (MA) Mayor Jon Mitchell, Conference Energy Committee Chair, said "History will judge the President harshly on this decision. Mayors have and will continue to step into the void left by the federal government. Cities have led the way on clean energy. Our mayoral influence will be felt around the world because of the example we have set."
Closing the call, Columbia (SC) Mayor Benjamin, USCM Second Vice President said, "Mayors across the country will continue to lead so we can protect our environment even from ourselves and present an America to our children that they deserve. Cities represent 75% of the world's energy consumption, so the leadership we are seeing at the local level in cities across the country can make a huge difference. We would love to be partners with the Environment Protection Agency, but if we are required to be adversaries because the agency has decided to work against the public interest, then we are prepared to do so."
Since 2005, the Conference has been a leader on the issue of climate change by passing numerous policies, holding several summits, as well as spearheading a bipartisan effort where more than 1,000 mayors committed to reduce greenhouse gas emissions in their individual communities.
See a sampling of USCM reports below:
"U.S. Mayors Report on a Decade of Global Climate Leadership" was issued on the eve of the COP21 in Paris where 35 U.S. mayors shared their stories on a decade of local climate leadership on their city efforts to reduce greenhouse gas emissions. (Report includes Mayors Climate Protection Agreement and list of mayoral signatory cities)
"How Energy Technologies Are Reshaping America's Cities" is a mayoral survey (178 mayors) providing data on how new energy technologies are being deployed in U.S. cities as part of the many ongoing efforts to curb greenhouse gas emissions.
"Climate Mitigation and Adaptation Actions in America's Cities" is a mayoral survey (282 mayors) describing ongoing climate-related actions and practices in cities.
"Successful City Initiatives with Energy Efficiency and Conservation Block Grant (EECBG) Funding " is a mayoral survey (204 mayors) showing how ARRA-based funding was used to accelerate city energy and climate initiatives to cut greenhouse gases and secure other benefits in the wake of the 2008 economic downturn.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/de01b56e-729e-48a5-b7dd-fc82360c0ac1
The U.S. Conference of Mayors
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: The U.S. Conference of Mayors via Globenewswire
Om NASDAQ OMX
NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.
Følg saker fra NASDAQ OMX
Registrer deg med din epostadresse under for å få de nyeste sakene fra NASDAQ OMX på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra NASDAQ OMX
XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer18.10.2017 16:53 | Pressemelding
AUSTIN, Texas, Oct. 18, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today enrollment of the first patient into a Phase I single arm study evaluating the maximum tolerated dose of Onivyde® (Irinotecan liposome injection) and 5-fluorouracil/folinic acid in combination with MABp1 in a cohort of patients with advanced pancreatic adenocarcinoma and cachexia. The patient has begun treatment at Cedars-Sinai Medical Center under the care of Dr. Andrew Hendifar, the Study's Principle Investigator, Medical Oncology lead for the Gastrointestinal Disease Research Group and Co-Director of Pancreas Oncology at Cedars-Sinai. A total of 16 patients are expected to be enrolled in the study. Dr. Hendifar commented, "We are excited to enroll our first patient in this novel combinatorial therapy for the treatment of advanced pancreatic cancer and cachexia. This is the first attempt to add an anti-inflammatory therapy to standard chemotherapy in an effort to improve the performanc
Nasdaq and SGX Establish Collaborative Listings Agreement18.10.2017 15:42 | Pressemelding
NEW YORK and SINGAPORE, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Nasdaq Inc. (Nasdaq:NDAQ) and Singapore Exchange (SGX) today announced the signing of a collaborative agreement in a move to leverage their strengths as two of the leading listings venues in the U.S. and Asia respectively. The new agreement seeks to enhance the channels available for companies to access capital market funding and enhance their corporate profile in both markets. As part of this agreement, Nasdaq and SGX -- who also share a successful, long-term market technology relationship -- are currently exploring the demand among corporates for a concurrent or sequential listing on both exchanges. Nasdaq and SGX are committed to supporting companies that are interested in pursuing this route. "The business landscape today is borderless," said Loh Boon Chye, CEO, SGX. "Fast-growing Asian companies looking to tap the capital markets can choose to list on SGX on Asian home ground, and embark on a listing on Nasdaq
Colliers International Expands in Washington, D.C.18.10.2017 14:30 | Pressemelding
Acquisition of Beltway Real Estate Services Firm Strengthens Ongoing Commitment to the Region TORONTO and WASHINGTON, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Leading global commercial real estate services firm Colliers International Group Inc. (NASDAQ:CIGI)(TSX:CIGI) announced today the acquisition of leading tenant representation advisory firm Serten Advisors. With its office in Tysons Corner, the firm serves global, national, and regional clients with a highly skilled and experienced team of professionals that have more than 100 years of combined experience. "This strategic acquisition positions Colliers to gain additional market share and win new business in the vibrant and competitive Suburban DC markets," said Marty Pupil, Colliers International President | U.S. Brokerage. "Adding Steve and Paul and the rest of their talented leadership team to our existing group of professionals in the region will further position Colliers as the commercial real estate services firm of
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC18.10.2017 14:00 | Pressemelding
InSphero AG / InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. New 3D InSight(TM) Human Liver Fibrosis Model represents a powerful tool for screening efficacy and safety of anti-fibrotic drugs in vitro. Schlieren, Switzerland, Oct. 18, 2017 (GLOBE NEWSWIRE) -- InSphero AG, the leading supplier of assay-ready 3D cell culture models for accelerating drug discovery and development, will present data characterizing and demonstrating the utility of its new 3D InSight(TM) Human Liver Fibrosis Model for screening efficacy of anti-fibrotic drugs. The findings will be presented at oral and poster presentations this Friday at the annual meeting of the American Association for the Study of Liver Disease (AASLD) Conference in Washington, DC. Anti-fibrotic therapi
Kofax Wins "Most Innovative Solution for Banking Customer Authentication" Award for Third Consecutive Year18.10.2017 08:00 | Pressemelding
Grand Prix Banque & Innovation Honor Recognizes Kofax Mobile ID Customer Onboarding Solution and its Anti-Fraud Capabilities IRVINE, Calif., Oct. 18, 2017 (GLOBE NEWSWIRE) -- Kofax ®, a leading provider of software to simplify and transform the First Mile(TM) of business, today announced that Kofax Mobile ID(TM) has won "Most Innovative Solution for Banking Customer Authentication" in the 2017 Grand Prix Banque & Innovation Awards in Paris, France. Now in its fourth year, the Awards identify excellence and innovation in the banking sector. The program acknowledges technology companies that have launched and implemented the most outstanding banking-related software solutions, initiatives and projects in France over the past twelve months. This award highlights the new facial recognition and ID verificationfeatures of Kofax Mobile ID that determine the authenticity and validity of identification documents and their holders.
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer18.10.2017 06:25 | Pressemelding
YOKOHAMA, Japan, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung cancer and improve quality of life for lung cancer patients. Innovations in lung cancer treatment linked to the discovery of PD-1 Prof. Tasuku Honjo of Japan, who was the first to identify PD-1 in 1992, shared an update on how PD-1 blockers have been widely used to treat many types of cancers. After decades of study, research into PD-1 has led to breakthrough immunotherapy treatments that are being hailed as a "penicillin moment" in cancer treatment. "I believe that, just as a number of antibiotics developed in the wake of the discovery of penicillin now p
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom